Yuanyuan Zou

Statistics

Publications

Citations

116

H-Index

Active since

2012

Affiliations

The First People's Hospital of Xiaoshan District, Hangzhou(Current)

Yuanyuan Zou is an author at The First People's Hospital of Xiaoshan District, Hangzhou specializing in nf-κb signaling, treatment, and retinal neurobiology.

ORCID

Publications per year

2012–2023

Publications

Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial

Guoming Li, Mei Yuan, Haihong Li et al. · International Journal of Antimicrobial Agents · 2020 · 62 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

p38 mitogen-activated protein kinase-induced nuclear factor kappa-light-chain-enhancer of activated B cell activity is required for neuroprotection in retinal ischemia/reperfusion injury.

Shaoyun Jiang, Yuanyuan Zou, Jiantao Wang · PubMed · 2012 · 20 citations · Full text

Life Sciences, Cell Biology, Ophthalmology +15

Development of a novel necroptosis-associated miRNA risk signature to evaluate the prognosis of colon cancer patients

Yang Huang, Yuanyuan Zou, Qiru Xiong et al. · Annals of Translational Medicine · 2021 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +17

Baicalein, a component of banxia xiexin decoction, alleviates <scp>CPT</scp>‐11‐induced gastrointestinal dysfunction by inhibiting <scp>ALOX15</scp>‐mediated ferroptosis

Jingbo Pei, Yuanyuan Zou, Wenying Zhou et al. · Chemical Biology & Drug Design · 2023 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

1–4 of 4